132 related articles for article (PubMed ID: 15546713)
1. Synthesis and interfacial behavior of sulfur-containing analogs of lung surfactant dipalmitoyl phosphatidylcholine.
Chang Y; Wang Z; Notter RH; Wang Z; Qu L; Schwan AL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5983-6. PubMed ID: 15546713
[TBL] [Abstract][Full Text] [Related]
2. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
Holm BA; Wang Z; Egan EA; Notter RH
Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
[TBL] [Abstract][Full Text] [Related]
3. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.
Wang Z; Schwan AL; Lairson LL; O'Donnell JS; Byrne GF; Foye A; Holm BA; Notter RH
Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L550-9. PubMed ID: 12902318
[TBL] [Abstract][Full Text] [Related]
4. Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins.
Chang Y; Wang Z; Schwan AL; Wang Z; Holm BA; Baatz JE; Notter RH
Chem Phys Lipids; 2005 Oct; 137(1-2):77-93. PubMed ID: 16109391
[TBL] [Abstract][Full Text] [Related]
5. Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids.
Wang Z; Hall SB; Notter RH
J Lipid Res; 1995 Jun; 36(6):1283-93. PubMed ID: 7666006
[TBL] [Abstract][Full Text] [Related]
6. Effects of albumin and erythrocyte membranes on spread monolayers of lung surfactant lipids.
Rachana R; Banerjee R
Colloids Surf B Biointerfaces; 2006 Jun; 50(1):9-17. PubMed ID: 16650737
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis and surface activity of lung surfactant phospholipid analogs. II. Racemic N-substituted diether phosphonolipids.
Turcotte JG; Lin WH; Pivarnik PE; Sacco AM; Shirali SS; Bermel MM; Lu Z; Notter RH
Biochim Biophys Acta; 1991 Jun; 1084(1):1-12. PubMed ID: 2054372
[TBL] [Abstract][Full Text] [Related]
8. Acylation of pulmonary surfactant protein-C is required for its optimal surface active interactions with phospholipids.
Wang Z; Gurel O; Baatz JE; Notter RH
J Biol Chem; 1996 Aug; 271(32):19104-9. PubMed ID: 8702584
[TBL] [Abstract][Full Text] [Related]
9. Chemical synthesis and surface activity of lung surfactant phospholipid analogs. III. Chiral N-substituted ether-amide phosphonolipids.
Turcotte JG; Lin WH; Motola NC; Pivarnik PE; Bhongle NN; Heyman HR; Shirali SS; Lu Z; Notter RH
Chem Phys Lipids; 1991; 58(1-2):81-95. PubMed ID: 1934196
[TBL] [Abstract][Full Text] [Related]
10. Lipid composition greatly affects the in vitro surface activity of lung surfactant protein mimics.
Seurynck-Servoss SL; Brown NJ; Dohm MT; Wu CW; Barron AE
Colloids Surf B Biointerfaces; 2007 May; 57(1):37-55. PubMed ID: 17287113
[TBL] [Abstract][Full Text] [Related]
11. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
Chimote G; Banerjee R
Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):215-23. PubMed ID: 16198543
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and surface activity of diether-linked phosphoglycerols: potential applications for exogenous lung surfactants.
Notter RH; Wang Z; Wang Z; Davy JA; Schwan AL
Bioorg Med Chem Lett; 2007 Jan; 17(1):113-7. PubMed ID: 17055273
[TBL] [Abstract][Full Text] [Related]
13. Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in interactions with phospholipids.
Wang Z; Gurel O; Baatz JE; Notter RH
J Lipid Res; 1996 Aug; 37(8):1749-60. PubMed ID: 8864959
[TBL] [Abstract][Full Text] [Related]
14. Real-time investigation of lung surfactant respreading with surface vibrational spectroscopy.
Ma G; Allen HC
Langmuir; 2006 Dec; 22(26):11267-74. PubMed ID: 17154614
[TBL] [Abstract][Full Text] [Related]
15. Effect of antitubercular drugs on dipalmitoylphosphatidylcholine monolayers: implications for drug loaded surfactants.
Chimote G; Banerjee R
Respir Physiol Neurobiol; 2005 Jan; 145(1):65-77. PubMed ID: 15652789
[TBL] [Abstract][Full Text] [Related]
16. New insights into lung surfactant monolayers using vibrational sum frequency generation spectroscopy.
Ma G; Allen HC
Photochem Photobiol; 2006; 82(6):1517-29. PubMed ID: 16930094
[TBL] [Abstract][Full Text] [Related]
17. Interfacial organizations of gel phospholipid and cholesterol in bovine lung surfactant films.
Nag K; Fritzen-Garcia M; Devraj R; Panda AK
Langmuir; 2007 Apr; 23(8):4421-31. PubMed ID: 17341098
[TBL] [Abstract][Full Text] [Related]
18. Hysteresis behavior of amphiphilic model peptide in lung lipid monolayers at the air-water interface by an IRRAS measurement.
Nakahara H; Dudek A; Nakamura Y; Lee S; Chang CH; Shibata O
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):61-7. PubMed ID: 18977123
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium on the surface properties of phospholipid monolayers with respect to surfactant formulations in respiratory distress syndrome.
Banerjee R; Bellare J
Biomed Mater Eng; 2001; 11(1):43-53. PubMed ID: 11281578
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the in situ structural and interfacial properties of the cationic hydrophobic heteropolypeptide, KL4, in lung surfactant bilayer and monolayer models at the air-water interface: implications for pulmonary surfactant delivery.
Mansour HM; Damodaran S; Zografi G
Mol Pharm; 2008; 5(5):681-95. PubMed ID: 18630875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
